Diffuse large B-cell lymphoma trials in Lithuania

1 of 2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

  Where

  Vilnius

  Age

  18 years to 70 years

  People

  213 worldwide

  Run by

  Miltenyi Biomedicine GmbH

  See details and how to joinNCT04844866 · EU 2023-506270-13-00